Aveanna Healthcare Holdings (AVAH) EBITDA (2020 - 2026)

Aveanna Healthcare Holdings (AVAH) has 7 years of EBITDA data on file, last reported at $71.0 million in Q1 2026.

• For the quarter ending Q1 2026, EBITDA rose 55.22% year-over-year to $71.0 million; the trailing twelve-month figure through Jan 2026 stood at $256.5 million (up 83.47% YoY), and the FY2026 full-year result was $266.3 million, up 78.24% from the prior year.
• EBITDA for Q1 2026 stood at $71.0 million, up from $53.6 million in the prior quarter.
• Across five years, EBITDA topped out at $80.0 million in Q2 2025 and bottomed at -$456.4 million in Q3 2022.
• The 5-year median for EBITDA is $29.3 million (2023), against an average of -$14.9 million.
• The widest annual swing landed in 2023, when EBITDA plunged 1694.99%; it then jumped 144.56% in 2024.
• A 5-year view of EBITDA shows it stood at -$204.5 million in 2022, then jumped by 114.33% to $29.3 million in 2023, then soared by 56.25% to $45.8 million in 2024, then gained by 17.07% to $53.6 million in 2025, then jumped by 32.59% to $71.0 million in 2026.
• The last three EBITDA figures came in at $71.0 million (Q1 2026), $53.6 million (Q3 2025), and $80.0 million (Q2 2025), per Business Quant data.

Peer Comparison